Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

BRAF inhibitors elicit rapid anti-tumor responses in the majority of patients with (V600)BRAF mutant melanoma, but acquired drug resistance is almost universal. We sought to identify the core resistance pathways and the extent of tumor heterogeneity during disease progression. We show that MAPK reac...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Shi, Hubing, Hugo, Willy, Kong, Xiangju, Hong, Aayoung, Koya, Richard C., Moriceau, Gatien, Chodon, Thinle, Guo, Rongqing, Johnson, Douglas B., Dahlman, Kimberly B., Kelley, Mark C., Kefford, Richard F., Chmielowski, Bartosz, Glaspy, John A., Sosman, Jeffrey A., van Baren, Nicolas, Long, Georgina V., Ribas, Antoni, Lo, Roger S.
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3936420/
https://ncbi.nlm.nih.gov/pubmed/24265155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0642
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы